April 24, 2026 AI-Powered Cell Squeezing Technology Advances Breast Cancer Risk Detection by City of Hope and UC Berkeley Researchers
April 22, 2026 Overcoming Resistance and RevMed’s Next Drug: RM-055 as a Catalytic Inhibitor in the RAS Inhibitor Arms Race
April 22, 2026 Sweden Recommends Low-Dose Aspirin for Specific Patients Starting January 2026, Based on Research Showing Cancer Cell Suppression via Immune Cell Activation in Animal Studies
